203 related articles for article (PubMed ID: 27804166)
1. Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments.
Jaki T; Vasileiou D
Stat Med; 2017 Feb; 36(4):563-580. PubMed ID: 27804166
[TBL] [Abstract][Full Text] [Related]
2. Multi-arm multi-stage (MAMS) randomised selection designs: impact of treatment selection rules on the operating characteristics.
Choodari-Oskooei B; Blenkinsop A; Handley K; Pinkney T; Parmar MKB
BMC Med Res Methodol; 2024 Jun; 24(1):124. PubMed ID: 38831421
[TBL] [Abstract][Full Text] [Related]
3. Adding new experimental arms to randomised clinical trials: Impact on error rates.
Choodari-Oskooei B; Bratton DJ; Gannon MR; Meade AM; Sydes MR; Parmar MK
Clin Trials; 2020 Jun; 17(3):273-284. PubMed ID: 32063029
[TBL] [Abstract][Full Text] [Related]
4. Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study.
Jaki T; Wason JMS
BMC Cardiovasc Disord; 2018 Nov; 18(1):215. PubMed ID: 30482176
[TBL] [Abstract][Full Text] [Related]
5. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
Lin J; Bunn V
Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
[TBL] [Abstract][Full Text] [Related]
6. Controlling the family-wise error rate in multi-arm, multi-stage trials.
Crouch LA; Dodd LE; Proschan MA
Clin Trials; 2017 Jun; 14(3):237-245. PubMed ID: 28545335
[TBL] [Abstract][Full Text] [Related]
7. Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes.
Bratton DJ; Parmar MK; Phillips PP; Choodari-Oskooei B
Trials; 2016 Jul; 17(1):309. PubMed ID: 27369182
[TBL] [Abstract][Full Text] [Related]
8. Two-stage response adaptive randomization designs for multi-arm trials with binary outcome.
Lu X; Shan G
J Biopharm Stat; 2024 Jul; 34(4):526-538. PubMed ID: 37452825
[TBL] [Abstract][Full Text] [Related]
9. A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials.
Wason JM; Trippa L
Stat Med; 2014 Jun; 33(13):2206-21. PubMed ID: 24421053
[TBL] [Abstract][Full Text] [Related]
10. Factorial designs: an overview with applications to orthodontic clinical trials.
Pandis N; Walsh T; Polychronopoulou A; Katsaros C; Eliades T
Eur J Orthod; 2014 Jun; 36(3):314-20. PubMed ID: 23885023
[TBL] [Abstract][Full Text] [Related]
11. Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial.
Choodari-Oskooei B; Thwin SS; Blenkinsop A; Widmer M; Althabe F; Parmar MK
Clin Trials; 2023 Feb; 20(1):71-80. PubMed ID: 36647713
[TBL] [Abstract][Full Text] [Related]
12. Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently.
White IR; Choodari-Oskooei B; Sydes MR; Kahan BC; McCabe L; Turkova A; Esmail H; Gibb DM; Ford D
Clin Trials; 2022 Aug; 19(4):432-441. PubMed ID: 35579066
[TBL] [Abstract][Full Text] [Related]
13. A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis.
Bratton DJ; Phillips PP; Parmar MK
BMC Med Res Methodol; 2013 Nov; 13():139. PubMed ID: 24229079
[TBL] [Abstract][Full Text] [Related]
14. Current practice in methodology and reporting of the sample size calculation in randomised trials of hip and knee osteoarthritis: a protocol for a systematic review.
Copsey B; Dutton S; Fitzpatrick R; Lamb SE; Cook JA
Trials; 2017 Oct; 18(1):466. PubMed ID: 29017518
[TBL] [Abstract][Full Text] [Related]
15. Non-factorial analyses of two-by-two factorial trial designs.
Korn EL; Freidlin B
Clin Trials; 2016 Dec; 13(6):651-659. PubMed ID: 27439306
[TBL] [Abstract][Full Text] [Related]
16. The effect of heterogeneous variance on efficiency and power of cluster randomized trials with a balanced 2 × 2 factorial design.
Lemme F; van Breukelen GJ; Candel MJ; Berger MP
Stat Methods Med Res; 2015 Oct; 24(5):574-93. PubMed ID: 25911332
[TBL] [Abstract][Full Text] [Related]
17. A web application for the design of multi-arm clinical trials.
Grayling MJ; Wason JM
BMC Cancer; 2020 Jan; 20(1):80. PubMed ID: 32005187
[TBL] [Abstract][Full Text] [Related]
18. Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework.
Blenkinsop A; Parmar MK; Choodari-Oskooei B
Clin Trials; 2019 Apr; 16(2):132-141. PubMed ID: 30648428
[TBL] [Abstract][Full Text] [Related]
19. When should factorial designs be used for late-phase randomised controlled trials?
White IR; Szubert AJ; Choodari-Oskooei B; Walker AS; Parmar MK
Clin Trials; 2024 Apr; 21(2):162-170. PubMed ID: 37904490
[TBL] [Abstract][Full Text] [Related]
20. Designs for adding a treatment arm to an ongoing clinical trial.
Bennett M; Mander AP
Trials; 2020 Mar; 21(1):251. PubMed ID: 32143729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
